Project Grant HT94252510372
Award Date
6/1/25
Completion Date
5/31/29
Dollars Obligated
$3.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
The federal Project Grant award of $1,074,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the production of cultured red blood cells for sickle cell disease patient support at Brigham & Women's Hospital Inc., a prominent academic medical center in Boston, Massachusetts. The 4-year grant, with a performance period from June 1, 2025 to May 31, 2029, will fund advanced biomedical...
The federal Project Grant award in the amount of $462,000.00 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives at the Albert Einstein College of Medicine in Bronx, NY, focused on the proteomics of vascular wall aging. The research seeks to transform healthcare for military service members and the general public through innovative and impactful scientific...
The Albert Einstein College of Medicine, a private non-profit educational institution in the Bronx, New York, has been awarded a $672,000 Project Grant by the Defense Health Agency, a component of the Department of Defense. The grant, which runs from March 1, 2024 to February 29, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420) and will support research on "Clonal Hematopoiesis as a Driver of Therapeutic Resistance and Metastatic Relapse in Breast...
The U.S. Department of Defense's Defense Health Agency has awarded a $168,000 Project Grant titled "SENESCENCE-ASSOCIATED SOMATIC MUTATIONS IN LUNG CANCER ETIOLOGY" to the Albert Einstein College of Medicine, a private non-profit educational institution located in the Bronx, New York. The award, funded under the Military Medical Research and Development program (CFDA 12.420), will support basic, translational, and clinical research focused on improving the health and care of military...
The U.S. Department of Defense's Defense Health Agency awarded a $672,000 Project Grant to the Albert Einstein College of Medicine in Bronx, NY to support the "MRNA TRANSLATION AND IMMUNE RECOGNITION IN MYC-DRIVEN LYMPHOMA" research project. This grant is funded under the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research initiatives to transform healthcare for military service members and the broader public. The 2-year project,...
The U.S. Department of Defense's Defense Health Agency has awarded a $1,209,600.00 Project Grant to Albert Einstein College of Medicine in Bronx, New York under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will support a project titled "VALIDATION OF BIOMARKERS OF POST-TRAUMATIC SEIZURES IN AN OPTIMIZED MODEL OF TRAUMATIC BRAIN INJURY" with a completion date of June 30, 2026. Through this funding, Albert Einstein College of...
This $707,436 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports biomedical research at the Albert Einstein College of Medicine in the Bronx, New York. The project aims to investigate biomarker signatures of post-traumatic epileptogenesis and its treatments. The 2-year award period runs from May 1, 2025 to April 30, 2027. As a prominent research institution, Albert Einstein College of Medicine will...
New York University School of Medicine was awarded a $762,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund a research project titled "BEYOND VEXAS AND UBA1: IDENTIFICATION OF NOVEL DRIVERS OF MDS AUTOIMMUNE SYNDROMES" from June 15, 2023 through June 14, 2026. The grant supports research to identify novel drivers of myelodysplastic syndromes, blood disorders that can progress...
Albany Medical College received a $733,500 Project Grant award from the Defense Health Agency dated June 1, 2023 through May 31, 2026 under the Military Medical Research and Development federal grant program (CFDA 12.420). Through this award, Albany Medical College will conduct research investigating medical solutions for the battlefield by harnessing RVE1 to treat bone marrow failure. The Military Medical Research and Development program aims to transform military and public health through...
The Albert Einstein College of Medicine has been awarded a $168,000 Project Grant from the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the role of alpha1-3/4 fucosyltransferases-mediated E-selectin function in the bone metastasis of prostate cancer. The project aims to advance scientific understanding and develop new treatment approaches for this form of cancer that disproportionately affects military service members...